We found the results of Kfoury et al 1 very interesting, where the authors conclude between others that carotid endarterectomy (CEA) under general anesthesia was found to have a statistically significant higher risk of myocardial infarction (MI) compared to local anesthesia. Routine postoperative electrocardiogram (ECG) and cardiac enzymes were not performed in this study, but all patients were placed on telemetry postoperatively and patients who had significant changes in telemetry ECG strips or chest pain had a 12-lead ECG and cardiac enzymes drawn. The occurrence of MI was determined by new changes in ECG, such as ST changes or new-onset Q waves and/or positive cardiac enzymes. Their results seem to agree with a similar study generated by the same authors, where they prove that CEA under local anesthesia is superior compared to CEA under general anesthesia as far as postoperative MI is concerned. 2 The majority of published studies so far, comparing general versus local anesthesia, are retrospective studies utilizing large-scale databases. 3 However, the results of prospective studies seem to be opposing so far. The well-known GALA trial, a randomized controlled trial recruiting almost 3500 patients, concluded that there is no difference between the 2 types of anesthesia as far as MI is concerned. 4 Sbarigia et al randomized more than 100 patients as far as the anesthetic technique is concerned and showed a similar prevalence of patients who had myocardial ischemia and a similar number of ischemic episodes per patient, in both the groups. 5 However, in this study, the authors highlight the difficulty for further subgroup analysis and production of definitive conclusions due to the small number of coronary events observed in the study.
The last universal definition of MI 6 mentions the contribution of cardiac troponin in diagnosis of cardiac damage, and they recommend routine monitoring of cardiac biomarkers after major noncardiac surgery. We have shown in a prospective study that CEA is followed by an increase in cardiac troponin I (value >0.5 ng/mL) in 14% of all cases, although symptomatic cardiac ischemia is very low. Surprisingly, high-risk patients for CEA-as defined by the SAPPHIRE criteria-did not show an increased risk of postoperative cardiac damage compared to low-risk patients. 7 Given the increasing prevalence of asymptomatic myocardial ischemia after CEA or carotid angioplasty with stenting, prospective studies should be generated using strictly defined troponin thresholds rather than using the classic international MI definition. In this way, asymptomatic myocardial ischemia can be highlighted using a well-defined protocol of detection, and the real effect of anesthetic modality on postoperative cardiac outcome can be addressed.
